Eton Pharmaceuticals (ETON) Other Operating Expenses (2022)

Eton Pharmaceuticals' (ETON) quarterly Other Operating Expenses came in at $1.1 million in Q1 2022.

Eton Pharmaceuticals (ETON) Other Operating Expenses (2022) Analysis & Trends

Eton Pharmaceuticals has disclosed Other Operating Expenses across 1 years of filings, most recently posting $1.1 million for Q1 2022.

Other Operating Expenses for Q1 2022 came in at $1.1 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $1.1 million (changed N/A YoY), and the FY2024 annual result was -$6.6 million, down 308.81% from the prior year.
Other Operating Expenses came in at $1.1 million for Q1 2022 at Eton Pharmaceuticals.
In the past five years, Other Operating Expenses ranged from a high of $1.1 million in Q1 2022 to a low of $1.1 million in Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn
10	Eton Pharmaceuticals	806.97 Mn	781.03 Mn	13.10 Mn

Download Data

Date	Value
Mar 31, 2022	1.12 Mn